U.S. Food & Drug Administration (FDA)

Name: Pre-Manifest Genetic ALS and FTD Patient Listening Session with the FDA
Start: 2023-01-12T00:00:00+00:00
End: 2023-01-12T23:59:59+00:00
Location: Virtual